Vyome Holdings, Inc 8-K

What Happened

• Vyome Holdings, Inc. (ticker: HIND) filed a Current Report on Form 8-K on February 13, 2026 to furnish investor presentation materials.
• The filing attaches Exhibit 99.1, titled "VT-1953 Phase 2 Data Presentation," and states Company representatives intend to use these materials at investor conferences and other forums. The disclosure is furnished pursuant to Regulation FD.

Key Details

• Filing date: February 13, 2026.
• Attached exhibit: Exhibit 99.1 — "VT-1953 Phase 2 Data Presentation."
• Purpose: Presentation materials that may be disclosed at investor conferences and other public forums.
• No earnings, financial results, management changes, or other operational items were reported in this 8-K.

Why It Matters

• The furnished presentation contains Phase 2 clinical data for VT-1953, material information for investors tracking Vyome’s drug development progress.
• Because the company furnished the slides under Regulation FD, the information is intended to be public and broadly available; investors should review Exhibit 99.1 to assess any clinical or development updates.
• This 8-K is a disclosure of presentation materials only—not an earnings release or corporate governance change—so monitor the presentation content and subsequent company communications for any impact on outlook or valuation.